Introduction {#sec1-1}
============

Madelung's disease (MD) is a rare disorder of adipose tissue, characterised by disfiguring massive non-capsulated adipose tissue proliferations in the neck the shoulder, and the arms. It may be associated with gynecomastia or lipomastia nearly one-third of patients. The age peak is between 30 to 60 years of age with a male to female-ration of 15:1 to 30:1. The incidence is about one affected person in 25,000 inhabitants. Most cases are sporadic patients \[[@ref1], [@ref2]\].

The aetiology of MD is not well understood. Since 86 to \> 95% of patients report chronic alcohol consumption, secondary metabolic effect may be of importance \[[@ref2], [@ref3]\]. Alcohol can induce abnormalities in the catecholamine-adipose tissue interactions. Adrenergic lipolysis becomes impaired and may result in excessive adipose tissue. Furthermore, a reduction of mitochondrial enzymes and increased adipose tissue lipoprotein-lipase activity have been reported \[[@ref4]\].

Adipocytes in MD seem to be closer to brown adipocytes than to white adipocytes according to ultrastructural investigations. In culture, pre-adipocytes of MD develop large mitochondria with parallel cristae and show multi-vacuolar lipid deposits \[[@ref5]\]. Investigations on cultured pre-adipocytes demonstrated synthesis of inner mitochondrial membrane protein UCP-1, which is a selective marker of brown adipose tissue (BAT) \[[@ref6]\]. There are more arguments supporting MD as a disease of BAT: uncoupling protein-1 mRNA (selective BAT marker), and adipocyte fatty-acid protein-2 (a selective marker of BAT and immature adipocytes) have been observed in patients with MD in affected adipose tissue \[[@ref4]\].

Comparing affected and non-affected adipocytes of patients with MD disclosed not differences in their surface marker profile. However, adipose tissue-derived stem cells had a higher proliferative activity. There were marked changes in the genetic profile for proliferation control, mitochondria, and hormonal regulation demonstrated by polymerase chain reaction (PCR) arrays \[[@ref7]\].

MD patients show multiple comorbidities, such as hepatic disease (60%), metabolic syndrome (40%), chronic obstructive pulmonary disease (COPD; 23%), hypothyroidism (10%), malignant tumors of the upper airways (rarely), and chronic alcohol consumption (\> 95%) \[[@ref2]\].

MD must be differentiated from Cushing syndrome and syndromic lipomatosis types of the head and neck region such as Familial Multiple Lipomatosis (FML), Encephalo-Cranio-Cutaneous Lipomatosis (ECCL), Congenital Infiltrating Lipomatosis of the Face (CIL-F), and Nasopalpebral Lipoma-Coloboma Syndrome (NLCS) \[[@ref8], [@ref9]\].

Patients and Methods {#sec1-2}
====================

We searched our files for patients with MD seen at the Department of Dermatology and Allergology during 2007 to 2017, their clinical presentation, comorbidities, and three cases of surgical treatment.

Results {#sec1-3}
=======

We identified eight adult patients with MD, four males and four females. Most patients had significant metabolic comorbidities. Two underwent bypass surgery after myocardial infarction; two suffered from renal insufficiency. The demographics and co-morbidities are summarised in [Table 1](#T1){ref-type="table"} and Figures [1](#F1 F2 F3 F4 F5 F6 F7){ref-type="fig"} - [8](#F8){ref-type="fig"}.

###### 

Demographics, clinical findings, and comorbidities in MD

  Patient   Age (years)   Gender   Affected areas                              Co-morbidities
  --------- ------------- -------- ------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------
  1         75            Male     Neck, shoulders, gynecomastia               Hepatocellular carcinoma, alcoholic liver cirrhosis, compensated renal insufficiency
  2         67            Male     Neck                                        Hypertension
  3         68            Male     Neck, shoulders, upper arms, gynecomastia   Metabolic syndrome, myocardial infarction with bypass surgery, gonarthrosis
  4         60            Female   Neck, shoulders                             Cervical spine syndrome, bullous pemphigoid, myocardial infarction with bypass surgery, diabetes mellitus type II, arterial hypertension, osteoporosis
  5         84            Female   Neck, upper back                            
  6         66            Female   Neck, shoulders, arms, lipomastia           Cervical spine syndrome
  7         54            Male     Neck and upper back                         Arterial hypertension, hypothyreosis, pulmonary fibrosis
  8         79            Female   Neck, shoulders                             Renal nephrectomy after renal cell carcinoma, chronic anaemia, chronic renal insufficiency, arterial hypertension, cholecystolithiasis, knee-TEP-surgery

![Madelung's disease with major disfigurement (Case 1). (a) Massive enlargement of subcutaneous adipose tissue under the chin; (b) Severe gynecomastia](OAMJMS-5-427-g001){#F1}

![Moderate growth of adipose tissue of the neck in Madelung's disease with development of multiple telangiectasias (Case 2)](OAMJMS-5-427-g002){#F2}

![Improvement of Madelung's disease by tumescent liposuction (Case 3). Before treatment (a, b) and after liposuction (c, d)](OAMJMS-5-427-g003){#F3}

![Moderate growth of subcutaneous adipose tissue with some telangiectasias (Case 4)](OAMJMS-5-427-g004){#F4}

![Massive tumor-like swelling of the neck (Case 5) with obvious telangiectasias (a). (b) Operation situs demonstrates non-encapsulated subcutaneous adipose tissue. (c) Resection specimen with massive enlarged adipocytes. (d) Two days after surgery](OAMJMS-5-427-g005){#F5}

![Pseudo-athletic appearance in Madelung's disease (Case 6)](OAMJMS-5-427-g006){#F6}

![Fibrotic Madelung's disease with dynamic growth (a and b), relapse after lipectomy; Stepwise improvement by tumescent liposuction from (c, d) to (e, f)](OAMJMS-5-427-g007){#F7}

![Massive disfigurement of the pseudo-athletic type of Madelung's disease (Case 8)](OAMJMS-5-427-g008){#F8}

Surgical treatment {#sec2-1}
------------------

### Case 1 ([Fig. 3](#F3){ref-type="fig"}) {#sec3-1}

A 68-year-old male patient presented with symmetrical progressive lipomatosis of MD-type. He suffered from impairment of neck mobility and pain sensations. Therefore, he wanted treatment for the neck region.

His medical history was positive for arterial hypertension, hyperlipidemia, bypass surgery after myocardial infarction 2013 with oral anticoagulation, and gonarthrosis of the right knee.

On examination, there were massive disfiguring adipose tissue deposits on neck, shoulders, arms and gynecomastia. The largest neck circumference was 50 cm.

Laboratory investigations revealed the following pathologic parameters: GGT 3.45 µkat/l, (normal range \<1), CRP 15.4 mg/l (\< 5), creatinin 111µmol/l (\< 90).

Histology: the Diffuse non-septal proliferation of adult enlarged mono vacuolar adipocytes with infiltration of adjacent structures.

Treatment and Course: He had a lipectomy in a plastic surgical department six years ago that relapsed. We performed two sessions of tumescent liposuction. The total amount of lipoaspiration was 600 ml. The procedures were well tolerated. After the second liposuction, he developed a symptomatic met-hemoglobinemia that was treated by intravenous injection of toluidine blue solution.

### Case 2 ([Fig. 7](#F7){ref-type="fig"}) {#sec3-2}

A 54-year-old male patient presented with longstanding, progressive subcutaneous, symmetrical adipose tissue deposits on the neck and upper back. He had a relapse after lipectomy.

Treatment and course: We treated him in 2014 by two tumescent liposuction sessions. Although the lipoaspirate was only 500 ml, he reported on significant improvement of pain sensations and mobility. After two years, he experienced a partial relapse that was treated again by tumescent liposuction with good functional results (lipoaspirate 200 ml).

### Case 3 ([Fig. 5](#F5){ref-type="fig"}) {#sec3-3}

An 83-year-old female patient presented with large disfiguring lipoma-like subcutaneous masses of the neck region. We decided to perform combined lipectomy and dermato- lipectomy in general anaesthesia. Healing was unremarkable. The patient was satisfied by the functional and esthetic outcome. There was no relapse in the following 12 months.

Discussion {#sec1-4}
==========

MD can lead to severe clinical complications, such as mediastinal syndrome, tracheobronchial obstruction, dysphagia, dysphonia, limited mobility of the neck, and somatic and autonomic neuropathies \[[@ref6]\]. Such complications are an indication to surgical treatment \[[@ref2], [@ref10]\].

In the past, the only available treatment was open surgery \[[@ref11]\]. Open surgery is characterised by a high rate of complications, mostly due to the severe comorbidities in MD patients. In a large series of 59 MD patients, complications by surgery (lipectomy/ dermato- lipectomy) were observed in 17.8%. However, the authors preferred surgery in advanced cases \[[@ref4]\].

Since relapses occur frequently, less invasive techniques were developed -- either as adjuvant treatment or as a substitute for extensive classical surgery such as injection lipolysis and tumescent liposuction \[[@ref12]-[@ref14]\]. Injection lipolysis, however, causes fibrosis and adhesions which prohibit the use of liposuction in the case of recurrence and possibly complicates lipectomy surgery as well. It is therefore not considered as an ideal treatment for MD \[[@ref15]\].

Tumescent liposuction is an established technique not only for esthetic procedures but a variety of medical conditions. It offers a combination of adipose tissue removal and skin tightening \[[@ref16]\].

Constandinidis et al. (2003) used a combined lipectomy and liposuction in 11 patients with MD. They started with lipectomy in the first place followed by liposuction in a second "course with liposuction" being done at a second session. Their mean follow-up was 2.7 years. Nine of 11 patients were satisfied with the esthetic outcome. Two relapses after 1.5 years and two years were observed \[[@ref17]\].

In one study seven MD patients were treated by liposuction successfully. Mean follow-up of 18 months revealed a high patient satisfaction with the outcome of the procedure \[[@ref18]\].

We report on ten adult patients with MD. The clinical presentation can vary widely concerning the areas involved and the degree of disfigurement and functional impairment. Both the clinical features of MD and the frequent occurrence of comorbidities has an impact on treatment options. In case 1, lipectomy had been performed before the patient present to our department, but there was a significant relapse. In this patient as well as in the more limited type seen in case 2, liposuction in tumescent anaesthesia was a useful and safe procedure leading to minor down-time without extensive scars. In more advanced situations, lipectomy and dermato- lipectomy may be used in the first place as demonstrated in case 3. Surgical approaches are the only treatment options with a significant improvement of MD, often with improved functionality and satisfying esthetic outcome. Although alcohol abuse is a common pathology, there is no scientific proof for reduced risk of progression and relapses if the patient stops alcohol consumption. Nevertheless, comorbidities need to be considered for an optimal long-term outcome of patients with MD.

**Funding:** This research did not receive any financial support.

**Competing Interests:** The authors have declared that no competing interests exist.
